Didanosine ( DrugBank: Didanosine )

2 diseases

ID	Disease name (Link within this page)	Number of trials
25	Progressive multifocal leukoencephalopathy	2
265	Lipodystrophy	1

25. Progressive multifocal leukoencephalopathy

Clinical trials : 26 / Drugs : 35 - (DrugBank : 22) / Drug target genes : 8 - Drug target pathways : 37

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00001048 (ClinicalTrials.gov)	February 1998	2/11/1999	Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progres ...	A Phase II Multicenter Study Comparing Antiretroviral Therapy Alone to Antiretroviral Therapy Plus C ...	HIV Infections;Leukoencephalopathy, Progressive Multifocal	Drug: Filgrastim;Drug: Cytarabine;Drug: Zidovudine;Drug: Zalcitabine;Drug: Didanosine	National Institute of Allergy and Infectious Diseases (NIAID)	Bristol-Myers Squibb;Upjohn	Completed	18 Years	65 Years	All	90	Phase 2	United States
2	NCT00002274 (ClinicalTrials.gov)	October 1997	2/11/1999	A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine	An Open Label Study Regimen of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodef ...	HIV Infections;Leukoencephalopathy, Progressive Multifocal	Drug: Didanosine	Bristol-Myers Squibb	NULL	Completed	12 Years	N/A	Both		N/A	United States

Clinical trials : 112 / Drugs : 155 - (DrugBank : 55) / Drug target genes : 25 - Drug target pathways : 97

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00192660 (ClinicalTrials.gov)	February 2003	12/9/2005	HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)	Analysis of Lipodystrophy in HIV-Infected Individuals A Prospective, Non-randomised, 48 Week Study o ...	HIV-Associated Lipodystrophy Syndrome;Cardiovascular Disease	Drug: Lamivudine;Drug: Stavudine;Drug: Didanosine;Drug: Zidovudine;Drug: Tenofovir;Drug: Abacavir;Dr ...	Kirby Institute	St Vincent's Hospital, Sydney;National Heart, Lung, and Blood Institute (NHLBI)	Completed	18 Years	N/A	Both	80	Phase 4	Australia